title: Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?
authors.affiliation: Pulmonary Dept, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Exohi, Thessaloniki, 57010, Greece.
authors.forename: Katerina
authors.initials: K
authors.lastname: Manika
authors.forename: Kalliopi
authors.initials: K
authors.lastname: Chatzika
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Zarogoulidis
authors.forename: Ioannis
authors.initials: I
authors.lastname: Kioumis
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D001372:Aza Compounds / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D010865:Pilot Projects; D011446:Prospective Studies; D011804:Quinolines / Q000493:pharmacokinetics*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin